Henrik Hasle

Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel

A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndrome

Optimized cytogenetic risk-group stratification of <i>KMT2A</i>-rearranged pediatric acute myeloid leukemia

<i>ATM</i> germ line pathogenic variants affect outcomes in children with ataxia-telangiectasia and hematological malignancies

Selective pressures of platinum compounds shape the evolution of therapy-related myeloid neoplasms

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia

Early mortality in children with cancer in Denmark and Sweden: The role of social background in a setting with universal healthcare

Psychiatric disorders among survivors of childhood acute lymphoblastic leukemia in Denmark and Sweden

Comprehensive molecular and clinical characterization of &lt;i&gt;NUP98&lt;/i&gt; fusions in pediatric acute myeloid leukemia

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group

Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft

Educational attainment in survivors of childhood cancer in Denmark, Finland, and Sweden

Biallelic inactivation of the <scp><i>NF1</i></scp> tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workup

<i>ATM</i> Germline Pathogenic Variants Affect Treatment Outcomes in Children with Acute Lymphoblastic Leukemia/Lymphoma and Ataxia Telangiectasia

The impact of the temporal sequence of cranial radiotherapy and platin‐based chemotherapy on hearing impairment in pediatric and adolescent <scp>CNS</scp> and <scp>head‐and‐neck</scp> cancer patients: A report from the <scp>PanCareLIFE</scp> consortium

<i>UBTF</i> tandem Duplications Account for a Third of Advanced Pediatric MDS without Genetic Predisposition to Myeloid Neoplasia

A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era

Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Hematopoietic stem cell transplantation in children and adolescents with GATA2-related myelodysplastic syndrome

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic Indicators

Psychiatric disorders in childhood cancer survivors in Denmark, Finland, and Sweden: a register-based cohort study from the SALiCCS research programme

SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature

TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study

Association of unbalanced translocation der(1;7) with germline GATA2 mutations

Employment status and occupational positions of childhood cancer survivors from Denmark, Finland and Sweden: A Nordic register-based cohort study from the SALiCCS research programme

Cohort Profile: The Socioeconomic Consequences in Adult Life After Childhood Cancer in Scandinavia (SALiCCS) Research Programme

Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes

Childhood cancer: Survival, treatment modalities, late effects and improvements over time

Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency

Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study